Nobu Hospitality Announces Nobu Beach Inn, Barbuda
New Hotel and Residential Development Will Join the Established Nobu Barbuda Restaurant on the Scenic Caribbean Island NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Nobu Hospitality, the globally recognized luxury lifestyle brand co-founded by Robert De...
Datasea Announces Foundational Research Breakthrough in Ultrasonic-Enhanced Nanoscale Precision Control
Establishing an Engineering-Level Core Technology for Next-Generation Semiconductor Manufacturing Applications BEIJING, Feb. 18, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company...
Marvion Inc. Announces Two New Investors, Further Strengthening Capital Base and Advancing Strategic Growth
HONG KONG, Feb. 17, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") today announced that on February 2, 2026, the Company entered into Stock Purchase Agreements with two new investors. The transactions were duly...
Lufax Announces Filing of Its Annual Report on Form 20-F
SHANGHAI, Feb. 17, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it filed its Annual Report on Form 20-F for the fiscal year ended...
Lufax Announces Changes of Directors and Senior Management
SHANGHAI, Feb. 17, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced leadership transitions and new appointments to its Board of Directors and...
CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical trial in patients with advanced solid tumors. This marks a...
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003
SUZHOU, China, Feb. 14, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005) of the biparatopic HER2-targeting antibody-drug...
Beko Announces CEO Transition; Strategic Continuity and Sustainability to Remain Core Priorities
ISTANBUL, Feb. 14, 2026 /PRNewswire/ -- Beko (Arçelik A.Ş.) (Bloomberg: ARCLK TI) today announced that Hakan Bulgurlu will step down as Chief Executive Officer as of the company's next General Assembly, concluding an 11-year tenure during which he...
Ubie Announces Collaboration to Reinvent the Healthcare Digital Front Door
Ubie and Mayo Clinic collaborate with the goal of delivering a unified, AI-powered chat and voice platform to streamline healthcare access, reduce complexity and offer a best-in-class patient experience Natural conversations, instant answers, and a...
ECARX Announces Fourth Quarter 2025 Unaudited Financial Results
LONDON, Feb. 12, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced unaudited financial results for the quarter ended December 31, 2025. Ziyu Shen, ECARX Chairman and...